influenza vaccine + varicella vaccine

The drug name influenza vaccine-University of California, San Francisco-chickenpox refers to a specific vaccination protocol evaluated by the University of California, San Francisco (UCSF) in patients who have undergone hematopoietic stem cell transplantation (HSCT). This research (NCT00005843) focused on characterizing the serial immune response to both the seasonal influenza vaccine and the varicella (chickenpox) vaccine in the post-transplant period. The influenza vaccine component typically consists of inactivated viral fragments targeting surface proteins like hemagglutinin and neuraminidase to prevent seasonal respiratory infection. The varicella vaccine component is generally a live-attenuated preparation of the varicella-zoster virus (VZV), such as the Oka strain, designed to induce active immunity against chickenpox and its complications in immunocompromised populations.

Other names

influenza vaccine + chickenpox vaccineUCSF HSCT vaccination protocol